Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuven Agami

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
EMBO Reports|May 31, 2003
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vectorMarc van de Wetering, Irma Oving, Vanesa Muncan, et al.
The EMBO Journal|July 14, 2007
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferationCarlos le Sage, Remco Nagel, David A Egan, et al.
Molecular Cell|October 21, 2022
Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potentialYuval Malka, Ferhat Alkan, Shinyeong Ju, et al.
Cell Cycle (Georgetown, Tex.)|May 21, 2011
MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progressionMikael Lerner, Josefin Lundgren, Shahab Akhoondi, et al.
Cancer Letters|August 27, 2018
CUEDC1 is a primary target of ERα essential for the growth of breast cancer cellsRui Lopes, Gozde Korkmaz, Sonia Aristin Revilla, et al.
Hepatology (Baltimore, Md.)|March 6, 2026
Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through non-canonical SAGA-MYC signalling modulationNatalia Hermán-Sánchez, Maite G Fernández-Barrena, Paloma E Alañón-Martínez, et al.
Cancer Research|May 31, 2014
miR-155 drives telomere fragility in human breast cancer by targeting TRF1Roberto Dinami, Cristiana Ercolani, Eleonora Petti, et al.
Nature Communications|October 27, 2011
Selective inhibition of microRNA accessibility by RBM38 is required for p53 activityNicolas Léveillé, Ran Elkon, Veronica Davalos, et al.
Molecular Systems Biology|September 22, 2020
Proteomic patterns associated with response to breast cancer neoadjuvant treatmentAnjana Shenoy, Nishanth Belugali Nataraj, Gili Perry, et al.
Cell|April 17, 2012
The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sitesMathias Jenal, Ran Elkon, Fabricio Loayza-Puch, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
EMBO Reports|May 31, 2003
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vectorMarc van de Wetering, Irma Oving, Vanesa Muncan, et al.
The EMBO Journal|July 14, 2007
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferationCarlos le Sage, Remco Nagel, David A Egan, et al.
Molecular Cell|October 21, 2022
Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potentialYuval Malka, Ferhat Alkan, Shinyeong Ju, et al.
Cell Cycle (Georgetown, Tex.)|May 21, 2011
MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progressionMikael Lerner, Josefin Lundgren, Shahab Akhoondi, et al.
Cancer Letters|August 27, 2018
CUEDC1 is a primary target of ERα essential for the growth of breast cancer cellsRui Lopes, Gozde Korkmaz, Sonia Aristin Revilla, et al.
Hepatology (Baltimore, Md.)|March 6, 2026
Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through non-canonical SAGA-MYC signalling modulationNatalia Hermán-Sánchez, Maite G Fernández-Barrena, Paloma E Alañón-Martínez, et al.
Cancer Research|May 31, 2014
miR-155 drives telomere fragility in human breast cancer by targeting TRF1Roberto Dinami, Cristiana Ercolani, Eleonora Petti, et al.
Nature Communications|October 27, 2011
Selective inhibition of microRNA accessibility by RBM38 is required for p53 activityNicolas Léveillé, Ran Elkon, Veronica Davalos, et al.
Molecular Systems Biology|September 22, 2020
Proteomic patterns associated with response to breast cancer neoadjuvant treatmentAnjana Shenoy, Nishanth Belugali Nataraj, Gili Perry, et al.
Cell|April 17, 2012
The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sitesMathias Jenal, Ran Elkon, Fabricio Loayza-Puch, et al.
Pageof 14